INS and Insulin resistance: By activating S6K, mTORC1 promotes insulin resistance by inhibiting phosphorylation of insulin receptor substrates (IRS) (Figure 1) and attenuating the insulin-induced phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway (6).